Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Pediatric Perianal Fistulizing Crohn's Disease
NCT04791878Phase 1Terminated
- Start
- Apr 2021
- Primary completion
- Nov 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of mesenchymal stem cells in perianal fistula and Crohn's disease. Primary endpoint: Treatment related adverse events at 12 months. Started Apr 2021; status: terminated.
02
Drugs
mesenchymal stem cells
03
Conditions
perianal fistulaCrohn's disease
Beyond the preview
Go deeper on NCT04791878.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04791878.